Fructose-mediated damage to lens α-crystallin: Prevention by pyruvate

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1500, Issue 2, 2000, Pages 161-168

  Zhao, Wei ^a   Devamanoharan, Palaniyandi S ^a   Varma, Shambhu D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cataract; Fructose; Glycation; Lens crystallin; Oxygen radical; Pyruvate

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; CATALASE; CRYSTALLIN; FRUCTOSE; GAMMA CRYSTALLIN; PENTETIC ACID; PYRUVIC ACID; SUPEROXIDE DISMUTASE;

AGING; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACTOGENESIS; CATTLE; CONTROLLED STUDY; DIABETES MELLITUS; GLYCATION; IN VITRO STUDY; LENS; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS;

ANIMALS; ANTIOXIDANTS; CATALASE; CATARACT; CATTLE; CRYSTALLINS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FRUCTOSE; GLYCOSYLATION; OXIDATION-REDUCTION; PENTETIC ACID; PYRUVIC ACID; SCHIFF BASES; SUPEROXIDE DISMUTASE;

EID: 0033957904     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(99)00102-7     Document Type: Article

References (35)

1. R. Klein, B.E. Klein, Vision disorders in diabetes, in: M.J. Harris, R.F. Hammon (Eds.), Diabetic Data Compiled 1984, U.S. Government Printing Service, Washington, DC, 1985, pp. 1-36.
2. Kador P.F., Agaki Y., Terihashi H., Wyman M., Kinoshita J.H. Prevention of pericyte ghost formation in retinal capillaries of galactose fed dogs by aldose reductase inhibitors. Arch. Ophthalmol. 106:1988;1099-1102.
3. Engerman R.L., Kern T.S. Hyperglycemia and development of glomerular pathology: diabetes compared to galactosemia. Kidney Int. 36:1988;41-45.
4. Brownlee M., Vlassara H., Kooney T., Ulrich P., Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science. 232:1986;1629-1632.
5. Varma S.D., Kinoshita J.H. Sorbitol pathway in diabetic and galactosemic rat lens. Biochim. Biophys. Acta. 328:1974;632-640.
6. Kinoshita J.H. Mechanisms initiating cataract formation. Invest. Ophthalmol. Vis. Sci. 13:1974;713-724.
7. Van Heyningen R. Formation of polyols by the lens of the rat with sugar cataracts. Nature. 184:1959;194-196.
8. Kuck J.F. Jr. The formation of fructose in the ocular lens. Arch. Ophthalmol. 65:1961;100-106.
9. Kuck J.F. Jr. Carbohydrate metabolism of the lens in normal and precataractous changes. Invest. Ophthalmol. 4:1965;638-642.
10. Jedziniak J.A., Chylack L.T. Jr., Cheng H.M., Gillis M.K., Kalustian A.A., Tung W.H. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase. Invest. Ophthalmol. Vis. Sci. 20:1981;314-336.
11. Varma S.D., Schocket S.S., Richards R.D. Implications of aldose reductase in cataracts in human diabetes. Invest. Ophthal. Vis. Sci. 18:1979;237-241.
12. Lerner B., Varma S.D., Richards R.D. Polyol pathway metabolites in human cataracts: correlation of circulating glycosylated hemoglobin content and fasting blood glucose levels. Arch. Ophthalmol. 102:1984;917-920.
13. Zhao W., Devamanoharan P.S., Varma S.D. Fructose induced deactivation of glucose-6-phosphate dehydrogenase activity and its prevention by pyruvate: implications in cataract prevention. Free Radic. Res. 29:1998;315-320.
14. Suarez G., Maturana J., Oronsky A.L., Suarez C.R. Fructose-induced fluorescence generation of reductively methylated glycated bovine serum albumin: evidence for nonenzymic glycation of Amadori adducts. Biochim. Biophys. Acta. 1075:1991;12-19.
15. Bunn H.F., Higgins P.J. Reaction of monosaccharides with protein: possible evolutionary significance. Science. 213:1981;222-224.
16. Raza K., Harding J.J. Non-enzymic modification of lens proteins by glucose and fructose: effects of ibuprofen. Exp. Eye Res. 52:1991;205-212.
17. Henein M., Devamanoharan P.S., Ramachandran S., Varma S.D. Prevention of galactose cataracts by pyruvate. Lens Eye Toxicity Res. 9:1992;25-36.
18. Varma S.D., Devamanoharan P.S., Rutzen A.R., Ali A.H., Henein M. Attenuation of galactose-induced cataract by pyruvate. Free Rad. Res. 30:1999;253-263.
19. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. Anal. Biochem. 72:1975;248-254.
20. Laemilli U.K. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature. 227:1970;680-685.
21. Sashidhar R.B., Capoor A.K., Ramana D. Quantitation of ε-amino group using amino acids as reference standards by trinitrobenzene sulfonic acid. J. Immunol. Methods. 167:1994;121-127.
22. Hunt J.V., Dean R.T., Wolff S.P. Hydroxyl radical production and auto-oxidative glycosylation. Biochem. J. 256:1988;205-212.
23. Holleman M.A.F. Note on the action of oxygenated water on alpha-ketoacids and 1,2-diketones. Recl. Trav. Chi. Pays-bas Belg. 23:1904;169-172.
24. Varma S.D., Devamanoharan P.S., Morris S.M. Prevention of cataracts by nutritional and metabolic antioxidants. Crit. Rev. Food Sci. Nutr. 35:(1/2):1995;111-129.
25. Varma S.D., Devamanoharan P.S., Morris S.M. Photoinduction of cataracts in lens in vitro. Prevention by pyruvate. Exp. Eye Res. 50:1990;805-812.
26. Varma S.D., Ramachandran S., Devamanoharan P.S., Morris S.M., Ali A.H. Prevention of oxidative damage to rat lens in vitro by pyruvate: possible attenuation in vivo. Curr. Eye Res. 14:1995;643-649.
27. Stevens V.J., Rouzer C.A., Monnier V.M., Cerami A. Diabetic cataract formation and potential role of glycosylation of lens proteins. Proc. Natl. Acad. Sci. USA. 75:1978;2918-2922.
28. Monnier V.M., Steven V.J., Cerami A. Nonenzymatic glycosylation, sulphydryl oxidation and high molecular weight aggregation of lens proteins in experimental sugar cataracts. J. Exp. Med. 50:1979;1098-1117.
29. Swamy M.S., Abraham E.C. Lens protein composition, glycation and high molecular weight aggregation in ageing rats. Invest. Ophthalmol. Vis. Sci. 28:1987;1693-1701.
30. Baynes J.W. Role of oxidative stress in development complications in diabetes. Diabetes. 40:1991;405-412.
31. Van Boekel M.A.M., Hoenders H.J. Glycation of crystallins in lenses from aging and diabetic individuals. FEBS Lett. 314:1992;1-4.
32. Brownlee M., Vlasarra H., Kooney A., Ulrich P., Cerami A. Aminoguanidine prevents diabetes induced arterial wall protein crosslinking. Science. 232:1986;1629-1632.
33. Cherian M., Abraham E.C. Glycation of human lens crystallins: effect of age and aspirin treatment. Ophthalmic Res. 25:1993;349-354.
34. Varma S.D., Devamanoharan P.S., Ali A.H. Formation of advanced glycation end products in diabetes: prevention by pyruvate and α-keto glutarate. Mol. Cell. Biochem. 171:1997;23-28.
35. 2 in vitro. Biochem. Pharmacol. 25:1992;2501-2513.